Industry Research Reports
Home > Reports > Service & Software > Neurology CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Neurology CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Service & Software
Published Date: 2026-03-09
Pages: 131 Pages
Report ld: 6072912
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Neurology CRO Services Market Size(US$)
CAGR 2026-2032
5.3%
Market Size,2032
USD 1,090
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 799 million
Market Forecast in 2032(Value)
US$ 1,090 million
CAGR
5.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Neurology CRO Services was estimated to be worth US$ 763 million in 2025 and is projected to reach US$ 1090 million, growing at a CAGR of 5.3% from 2026 to 2032.
Neurology Contract Research Organization (CRO) services are specialized offerings provided by external entities to pharmaceutical companies, biotech firms, academic institutions, and other stakeholders engaged in neurological research and drug development. These CROs possess in-depth expertise in the complex field of neurology, encompassing a wide range of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. Their services span various stages of the research and development process. They are involved in the design and planning of clinical trials, carefully formulating study protocols, defining appropriate endpoints, and identifying suitable patient populations based on the specific neurological condition under investigation. Neurology CROs handle patient recruitment and enrollment, leveraging their networks with specialized neurology clinics, hospitals, and patient advocacy groups to ensure a diverse and representative sample of participants. They also manage data collection, analysis, and interpretation, dealing with the intricate data related to neurological symptoms, cognitive function, and biomarker measurements. Additionally, they offer regulatory support, helping clients navigate the complex and evolving regulatory landscape for neurological therapies, ensuring compliance with relevant guidelines. These services are essential for accelerating the development of effective treatments for neurological disorders, as they allow organizations to access the specialized skills, resources, and experience of the CROs, ultimately aiming to improve the lives of patients suffering from neurological conditions.
The North American market for Neurology CRO Services was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Neurology CRO Services was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Neurology CRO Services was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Neurology CRO Services market include Parexel, Atlantic Research Group, Linical, Biospective, InnoSer, MDB Neuro, Charles River Laboratories, MCRA, Syneos Health, Biotrial, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Neurology CRO Services, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Neurology CRO Services market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Neurology CRO Services.
MARKET SEGMENTATION
By Company
- Parexel
- Atlantic Research Group
- Linical
- Biospective
- InnoSer
- MDB Neuro
- Charles River Laboratories
- MCRA
- Syneos Health
- Biotrial
- Allucent
- Cromos Pharma
- Lindus Health
- TFS HealthScience
- Worldwide Clinical Trials
- Quotient Sciences
- PharPoint Research
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Clinical Trial Management Services
- Pre-clinical Research Services
- Others
Segment by Application
- Pharmaceutical Companies
- Academic Research Organizations
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Neurology CRO Services companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Neurology CRO Services revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Neurology CRO Services revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Neurology CRO Services Product Introduction
1.2 Global Neurology CRO Services Market Size Forecast (2021–2032)
1.3 Neurology CRO Services Market Trends & Drivers
1.3.1 Neurology CRO Services Industry Trends
1.3.2 Neurology CRO Services Market Drivers & Opportunities
1.3.3 Neurology CRO Services Market Challenges
1.3.4 Neurology CRO Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neurology CRO Services Players Revenue Ranking (2025)
2.2 Global Neurology CRO Services Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Neurology CRO Services Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Neurology CRO Services
2.6 Neurology CRO Services Market Competitive Analysis
2.6.1 Neurology CRO Services Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Neurology CRO Services Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Neurology CRO Services revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Neurology CRO Services Market Classification
3.1 Introduction by Type
3.1.1 Clinical Trial Management Services
3.1.2 Pre-clinical Research Services
3.1.3 Others
3.1.4 Global Neurology CRO Services Sales Value by Type
3.1.4.1 Global Neurology CRO Services Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Neurology CRO Services Sales Value, by Type (2021–2032)
3.1.4.3 Global Neurology CRO Services Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Companies
4.1.2 Academic Research Organizations
4.1.3 Others
4.2 Global Neurology CRO Services Sales Value by Application
4.2.1 Global Neurology CRO Services Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Neurology CRO Services Sales Value by Application (2021–2032)
4.2.3 Global Neurology CRO Services Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Neurology CRO Services Sales Value by Region
5.1.1 Global Neurology CRO Services Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Neurology CRO Services Sales Value by Region (2021–2026)
5.1.3 Global Neurology CRO Services Sales Value by Region (2027–2032)
5.1.4 Global Neurology CRO Services Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Neurology CRO Services Sales Value, 2021–2032
5.2.2 North America Neurology CRO Services Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Neurology CRO Services Sales Value, 2021–2032
5.3.2 Europe Neurology CRO Services Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Neurology CRO Services Sales Value, 2021–2032
5.4.2 Asia Pacific Neurology CRO Services Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Neurology CRO Services Sales Value, 2021–2032
5.5.2 South America Neurology CRO Services Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Neurology CRO Services Sales Value, 2021–2032
5.6.2 Middle East & Africa Neurology CRO Services Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neurology CRO Services Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Neurology CRO Services Sales Value, 2021–2032
6.3 United States
6.3.1 United States Neurology CRO Services Sales Value, 2021–2032
6.3.2 United States Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Neurology CRO Services Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Neurology CRO Services Sales Value, 2021–2032
6.4.2 Europe Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Neurology CRO Services Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Neurology CRO Services Sales Value, 2021–2032
6.5.2 China Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
6.5.3 China Neurology CRO Services Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Neurology CRO Services Sales Value, 2021–2032
6.6.2 Japan Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Neurology CRO Services Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Neurology CRO Services Sales Value, 2021–2032
6.7.2 South Korea Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Neurology CRO Services Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Neurology CRO Services Sales Value, 2021–2032
6.8.2 Southeast Asia Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Neurology CRO Services Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Neurology CRO Services Sales Value, 2021–2032
6.9.2 India Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
6.9.3 India Neurology CRO Services Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Parexel
7.1.1 Parexel Profile
7.1.2 Parexel Main Business
7.1.3 Parexel Neurology CRO Services Products, Services, and Solutions
7.1.4 Parexel Neurology CRO Services Revenue (US$ Million), 2021–2026
7.1.5 Parexel Recent Developments
7.2 Atlantic Research Group
7.2.1 Atlantic Research Group Profile
7.2.2 Atlantic Research Group Main Business
7.2.3 Atlantic Research Group Neurology CRO Services Products, Services, and Solutions
7.2.4 Atlantic Research Group Neurology CRO Services Revenue (US$ Million), 2021–2026
7.2.5 Atlantic Research Group Recent Developments
7.3 Linical
7.3.1 Linical Profile
7.3.2 Linical Main Business
7.3.3 Linical Neurology CRO Services Products, Services, and Solutions
7.3.4 Linical Neurology CRO Services Revenue (US$ Million), 2021–2026
7.3.5 Linical Recent Developments
7.4 Biospective
7.4.1 Biospective Profile
7.4.2 Biospective Main Business
7.4.3 Biospective Neurology CRO Services Products, Services, and Solutions
7.4.4 Biospective Neurology CRO Services Revenue (US$ Million), 2021–2026
7.4.5 Biospective Recent Developments
7.5 InnoSer
7.5.1 InnoSer Profile
7.5.2 InnoSer Main Business
7.5.3 InnoSer Neurology CRO Services Products, Services, and Solutions
7.5.4 InnoSer Neurology CRO Services Revenue (US$ Million), 2021–2026
7.5.5 InnoSer Recent Developments
7.6 MDB Neuro
7.6.1 MDB Neuro Profile
7.6.2 MDB Neuro Main Business
7.6.3 MDB Neuro Neurology CRO Services Products, Services, and Solutions
7.6.4 MDB Neuro Neurology CRO Services Revenue (US$ Million), 2021–2026
7.6.5 MDB Neuro Recent Developments
7.7 Charles River Laboratories
7.7.1 Charles River Laboratories Profile
7.7.2 Charles River Laboratories Main Business
7.7.3 Charles River Laboratories Neurology CRO Services Products, Services, and Solutions
7.7.4 Charles River Laboratories Neurology CRO Services Revenue (US$ Million), 2021–2026
7.7.5 Charles River Laboratories Recent Developments
7.8 MCRA
7.8.1 MCRA Profile
7.8.2 MCRA Main Business
7.8.3 MCRA Neurology CRO Services Products, Services, and Solutions
7.8.4 MCRA Neurology CRO Services Revenue (US$ Million), 2021–2026
7.8.5 MCRA Recent Developments
7.9 Syneos Health
7.9.1 Syneos Health Profile
7.9.2 Syneos Health Main Business
7.9.3 Syneos Health Neurology CRO Services Products, Services, and Solutions
7.9.4 Syneos Health Neurology CRO Services Revenue (US$ Million), 2021–2026
7.9.5 Syneos Health Recent Developments
7.10 Biotrial
7.10.1 Biotrial Profile
7.10.2 Biotrial Main Business
7.10.3 Biotrial Neurology CRO Services Products, Services, and Solutions
7.10.4 Biotrial Neurology CRO Services Revenue (US$ Million), 2021–2026
7.10.5 Biotrial Recent Developments
7.11 Allucent
7.11.1 Allucent Profile
7.11.2 Allucent Main Business
7.11.3 Allucent Neurology CRO Services Products, Services, and Solutions
7.11.4 Allucent Neurology CRO Services Revenue (US$ Million), 2021–2026
7.11.5 Allucent Recent Developments
7.12 Cromos Pharma
7.12.1 Cromos Pharma Profile
7.12.2 Cromos Pharma Main Business
7.12.3 Cromos Pharma Neurology CRO Services Products, Services, and Solutions
7.12.4 Cromos Pharma Neurology CRO Services Revenue (US$ Million), 2021–2026
7.12.5 Cromos Pharma Recent Developments
7.13 Lindus Health
7.13.1 Lindus Health Profile
7.13.2 Lindus Health Main Business
7.13.3 Lindus Health Neurology CRO Services Products, Services, and Solutions
7.13.4 Lindus Health Neurology CRO Services Revenue (US$ Million), 2021–2026
7.13.5 Lindus Health Recent Developments
7.14 TFS HealthScience
7.14.1 TFS HealthScience Profile
7.14.2 TFS HealthScience Main Business
7.14.3 TFS HealthScience Neurology CRO Services Products, Services, and Solutions
7.14.4 TFS HealthScience Neurology CRO Services Revenue (US$ Million), 2021–2026
7.14.5 TFS HealthScience Recent Developments
7.15 Worldwide Clinical Trials
7.15.1 Worldwide Clinical Trials Profile
7.15.2 Worldwide Clinical Trials Main Business
7.15.3 Worldwide Clinical Trials Neurology CRO Services Products, Services, and Solutions
7.15.4 Worldwide Clinical Trials Neurology CRO Services Revenue (US$ Million), 2021–2026
7.15.5 Worldwide Clinical Trials Recent Developments
7.16 Quotient Sciences
7.16.1 Quotient Sciences Profile
7.16.2 Quotient Sciences Main Business
7.16.3 Quotient Sciences Neurology CRO Services Products, Services, and Solutions
7.16.4 Quotient Sciences Neurology CRO Services Revenue (US$ Million), 2021–2026
7.16.5 Quotient Sciences Recent Developments
7.17 PharPoint Research
7.17.1 PharPoint Research Profile
7.17.2 PharPoint Research Main Business
7.17.3 PharPoint Research Neurology CRO Services Products, Services, and Solutions
7.17.4 PharPoint Research Neurology CRO Services Revenue (US$ Million), 2021–2026
7.17.5 PharPoint Research Recent Developments
8 Industry Chain Analysis
8.1 Neurology CRO Services Value Chain
8.2 Neurology CRO Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Neurology CRO Services Sales Model
8.5.2 Sales Channels
8.5.3 Neurology CRO Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Neurology CRO Services Market Trends
Table 2. Neurology CRO Services Market Drivers & Opportunities
Table 3. Neurology CRO Services Market Challenges
Table 4. Neurology CRO Services Market Restraints
Table 5. Global Neurology CRO Services Revenue by Company (US$ Million), 2021–2026
Table 6. Global Neurology CRO Services Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Neurology CRO Services Product Type
Table 9. Key Companies General Availability (GA) Timeline for Neurology CRO Services
Table 10. Global Neurology CRO Services Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Neurology CRO Services revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Neurology CRO Services Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Neurology CRO Services Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Neurology CRO Services Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Neurology CRO Services Sales Market Share in Value by Type (2021–2026)
Table 17. Global Neurology CRO Services Sales Market Share in Value by Type (2027–2032)
Table 18. Global Neurology CRO Services Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Neurology CRO Services Sales Value by Application (US$ Million), 2021–2026
Table 20. Global Neurology CRO Services Sales Value by Application (US$ Million), 2027–2032
Table 21. Global Neurology CRO Services Sales Market Share in Value by Application (2021–2026)
Table 22. Global Neurology CRO Services Sales Market Share in Value by Application (2027–2032)
Table 23. Global Neurology CRO Services Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 24. Global Neurology CRO Services Sales Value by Region (US$ Million), 2021–2026
Table 25. Global Neurology CRO Services Sales Value by Region (US$ Million), 2027–2032
Table 26. Global Neurology CRO Services Sales Value by Region (%), 2021–2026
Table 27. Global Neurology CRO Services Sales Value by Region (%), 2027–2032
Table 28. Key Countries/Regions Neurology CRO Services Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 29. Key Countries/Regions Neurology CRO Services Sales Value, (US$ Million), 2021–2026
Table 30. Key Countries/Regions Neurology CRO Services Sales Value, (US$ Million), 2027–2032
Table 31. Parexel Basic Information List
Table 32. Parexel Description and Business Overview
Table 33. Parexel Neurology CRO Services Products, Services, and Solutions
Table 34. Revenue (US$ Million) in Neurology CRO Services Business of Parexel (2021–2026)
Table 35. Parexel Recent Developments
Table 36. Atlantic Research Group Basic Information List
Table 37. Atlantic Research Group Description and Business Overview
Table 38. Atlantic Research Group Neurology CRO Services Products, Services, and Solutions
Table 39. Revenue (US$ Million) in Neurology CRO Services Business of Atlantic Research Group (2021–2026)
Table 40. Atlantic Research Group Recent Developments
Table 41. Linical Basic Information List
Table 42. Linical Description and Business Overview
Table 43. Linical Neurology CRO Services Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Neurology CRO Services Business of Linical (2021–2026)
Table 45. Linical Recent Developments
Table 46. Biospective Basic Information List
Table 47. Biospective Description and Business Overview
Table 48. Biospective Neurology CRO Services Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Neurology CRO Services Business of Biospective (2021–2026)
Table 50. Biospective Recent Developments
Table 51. InnoSer Basic Information List
Table 52. InnoSer Description and Business Overview
Table 53. InnoSer Neurology CRO Services Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Neurology CRO Services Business of InnoSer (2021–2026)
Table 55. InnoSer Recent Developments
Table 56. MDB Neuro Basic Information List
Table 57. MDB Neuro Description and Business Overview
Table 58. MDB Neuro Neurology CRO Services Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Neurology CRO Services Business of MDB Neuro (2021–2026)
Table 60. MDB Neuro Recent Developments
Table 61. Charles River Laboratories Basic Information List
Table 62. Charles River Laboratories Description and Business Overview
Table 63. Charles River Laboratories Neurology CRO Services Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Neurology CRO Services Business of Charles River Laboratories (2021–2026)
Table 65. Charles River Laboratories Recent Developments
Table 66. MCRA Basic Information List
Table 67. MCRA Description and Business Overview
Table 68. MCRA Neurology CRO Services Products, Services, and Solutions
Table 69. Revenue (US$ Million) in Neurology CRO Services Business of MCRA (2021–2026)
Table 70. MCRA Recent Developments
Table 71. Syneos Health Basic Information List
Table 72. Syneos Health Description and Business Overview
Table 73. Syneos Health Neurology CRO Services Products, Services, and Solutions
Table 74. Revenue (US$ Million) in Neurology CRO Services Business of Syneos Health (2021–2026)
Table 75. Syneos Health Recent Developments
Table 76. Biotrial Basic Information List
Table 77. Biotrial Description and Business Overview
Table 78. Biotrial Neurology CRO Services Products, Services, and Solutions
Table 79. Revenue (US$ Million) in Neurology CRO Services Business of Biotrial (2021–2026)
Table 80. Biotrial Recent Developments
Table 81. Allucent Basic Information List
Table 82. Allucent Description and Business Overview
Table 83. Allucent Neurology CRO Services Products, Services, and Solutions
Table 84. Revenue (US$ Million) in Neurology CRO Services Business of Allucent (2021–2026)
Table 85. Allucent Recent Developments
Table 86. Cromos Pharma Basic Information List
Table 87. Cromos Pharma Description and Business Overview
Table 88. Cromos Pharma Neurology CRO Services Products, Services, and Solutions
Table 89. Revenue (US$ Million) in Neurology CRO Services Business of Cromos Pharma (2021–2026)
Table 90. Cromos Pharma Recent Developments
Table 91. Lindus Health Basic Information List
Table 92. Lindus Health Description and Business Overview
Table 93. Lindus Health Neurology CRO Services Products, Services, and Solutions
Table 94. Revenue (US$ Million) in Neurology CRO Services Business of Lindus Health (2021–2026)
Table 95. Lindus Health Recent Developments
Table 96. TFS HealthScience Basic Information List
Table 97. TFS HealthScience Description and Business Overview
Table 98. TFS HealthScience Neurology CRO Services Products, Services, and Solutions
Table 99. Revenue (US$ Million) in Neurology CRO Services Business of TFS HealthScience (2021–2026)
Table 100. TFS HealthScience Recent Developments
Table 101. Worldwide Clinical Trials Basic Information List
Table 102. Worldwide Clinical Trials Description and Business Overview
Table 103. Worldwide Clinical Trials Neurology CRO Services Products, Services, and Solutions
Table 104. Revenue (US$ Million) in Neurology CRO Services Business of Worldwide Clinical Trials (2021–2026)
Table 105. Worldwide Clinical Trials Recent Developments
Table 106. Quotient Sciences Basic Information List
Table 107. Quotient Sciences Description and Business Overview
Table 108. Quotient Sciences Neurology CRO Services Products, Services, and Solutions
Table 109. Revenue (US$ Million) in Neurology CRO Services Business of Quotient Sciences (2021–2026)
Table 110. Quotient Sciences Recent Developments
Table 111. PharPoint Research Basic Information List
Table 112. PharPoint Research Description and Business Overview
Table 113. PharPoint Research Neurology CRO Services Products, Services, and Solutions
Table 114. Revenue (US$ Million) in Neurology CRO Services Business of PharPoint Research (2021–2026)
Table 115. PharPoint Research Recent Developments
Table 116. Revenue (US$ Million) in Neurology CRO Services Business of Company 40 (2021–2026)
Table 117. Company 40 Recent Developments
Table 118. Key Raw Materials Lists
Table 119. Key Suppliers of Raw Materials Lists
Table 120. Neurology CRO Services Downstream Customers
Table 121. Neurology CRO Services Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurology CRO Services Product Picture
Figure 2. Global Neurology CRO Services Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 4. Neurology CRO Services Report Years Considered
Figure 5. Global Neurology CRO Services Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Neurology CRO Services Revenue in 2025
Figure 7. Neurology CRO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Clinical Trial Management Services Picture
Figure 9. Pre-clinical Research Services Picture
Figure 10. Others Picture
Figure 11. Global Neurology CRO Services Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Neurology CRO Services Sales Value Market Share by Type, 2025 & 2032
Figure 13. Product Picture of Pharmaceutical Companies
Figure 14. Product Picture of Academic Research Organizations
Figure 15. Product Picture of Others
Figure 16. Global Neurology CRO Services Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Neurology CRO Services Sales Value Market Share by Application, 2025 & 2032
Figure 18. North America Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 19. North America Neurology CRO Services Sales Value by Country (%), 2025 vs 2032
Figure 20. Europe Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 21. Europe Neurology CRO Services Sales Value by Country (%), 2025 vs 2032
Figure 22. Asia Pacific Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 23. Asia Pacific Neurology CRO Services Sales Value by Subregion (%), 2025 vs 2032
Figure 24. South America Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 25. South America Neurology CRO Services Sales Value by Country (%), 2025 vs 2032
Figure 26. Middle East & Africa Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 27. Middle East & Africa Neurology CRO Services Sales Value by Country (%), 2025 vs 2032
Figure 28. Key Countries/Regions Neurology CRO Services Sales Value (%), 2021–2032
Figure 29. United States Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 30. United States Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
Figure 31. United States Neurology CRO Services Sales Value by Application (%), 2025 vs 2032
Figure 32. Europe Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 33. Europe Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
Figure 34. Europe Neurology CRO Services Sales Value by Application (%), 2025 vs 2032
Figure 35. China Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 36. China Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
Figure 37. China Neurology CRO Services Sales Value by Application (%), 2025 vs 2032
Figure 38. Japan Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 39. Japan Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
Figure 40. Japan Neurology CRO Services Sales Value by Application (%), 2025 vs 2032
Figure 41. South Korea Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 42. South Korea Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
Figure 43. South Korea Neurology CRO Services Sales Value by Application (%), 2025 vs 2032
Figure 44. Southeast Asia Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 45. Southeast Asia Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
Figure 46. Southeast Asia Neurology CRO Services Sales Value by Application (%), 2025 vs 2032
Figure 47. India Neurology CRO Services Sales Value (US$ Million), 2021–2032
Figure 48. India Neurology CRO Services Sales Value by Type (%), 2025 vs 2032
Figure 49. India Neurology CRO Services Sales Value by Application (%), 2025 vs 2032
Figure 50. Neurology CRO Services Value Chain
Figure 51. Neurology CRO Services Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Neurology CRO Services in 2032?
The global market size of Neurology CRO Services in 2032 was 1090 Million USD.
What was the global market size of Neurology CRO Services in 2026?
What is the annual compound growth rate of the global Neurology CRO Services market size from 2026 to 2032?
Which companies rank high in the global Neurology CRO Services market?
Which region is expected to have the highest market share?
Related Reports
Global Neurology CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1090 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 157
USD 4900.00
(Single User License)
Global Neurology CRO Services Market Research Report 2026
The global Neurology CRO Services market was valued at US$ 763 million in 2025 and is anticipated to reach US$ 1090 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 127
USD 2900.00
(Single User License)
Global Neurology CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurology CRO Services market size was US$ 763 million in 2025 and is forecast to reach a readjusted size of US$ 1090 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 104
USD 4250.00
(Single User License)
Neurology CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurology CRO Services was estimated to be worth US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-05-08
Pages: 122
USD 3950.00
(Single User License)
Global Neurology CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurology CRO Services market size was US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-05-08
Pages: 106
USD 4250.00
(Single User License)
Global Neurology CRO Services Market Insights, Forecast to 2031
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
Published Date: 2025-05-08
Pages: 156
USD 4900.00
(Single User License)
Global Neurology CRO Services Market Research Report 2025
The global market for Neurology CRO Services was valued at US$ 724 million in the year 2024 and is projected to reach a revised size of US$ 1040 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published Date: 2025-05-08
Pages: 91
USD 2900.00
(Single User License)
Global Neurology CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1090 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 157
USD 4900.00 (Single User License)Global Neurology CRO Services Market Research Report 2026
The global Neurology CRO Services market was valued at US$ 763 million in 2025 and is anticipated to reach US$ 1090 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-11
Pages: 127
USD 2900.00 (Single User License)Global Neurology CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurology CRO Services market size was US$ 763 million in 2025 and is forecast to reach a readjusted size of US$ 1090 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 104
USD 4250.00 (Single User License)Neurology CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurology CRO Services was estimated to be worth US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 122
USD 3950.00 (Single User License)Global Neurology CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurology CRO Services market size was US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 106
USD 4250.00 (Single User License)Global Neurology CRO Services Market Insights, Forecast to 2031
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
Published: 2025-05-08
Pages: 156
USD 4900.00 (Single User License)Global Neurology CRO Services Market Research Report 2025
The global market for Neurology CRO Services was valued at US$ 724 million in the year 2024 and is projected to reach a revised size of US$ 1040 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published: 2025-05-08
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now